Home · Pharmacies · MediVera Compounding Pharmacy
Compounding pharmacy profileMediVera Compounding Pharmacy: what the records show
As of October 14, 2026, MediVera Compounding Pharmacy (Diversified Pharmacy Inc., Troy, Michigan; formerly University Compounding Pharmacy) is a 503A compounding pharmacy that says it holds PCAB accreditation for sterile and non-sterile compounding and is licensed in 49 states. Its current weight-management page lists compounded liraglutide, not tirzepatide, and we found no FDA warning letters or Form 483s for it from 2023 to 2026.
MediVera at a glance
| Legal name | Diversified Pharmacy Inc. (doing business as MediVera Compounding Pharmacy) |
|---|---|
| Location | 5225 Crooks Rd, Troy, MI 48098 |
| Type | 503A compounding pharmacy |
| On FDA 503B list | No |
| Accreditations it claims | PCAB, sterile and non-sterile, since 2017 — not independently verified |
| States | Says it is licensed in 49 states |
| GLP-1 products it lists | Compounded liraglutide injection (current page); semaglutide mentioned in a 2024 post |
| FDA actions 2023–2026 | None found |
| History | Rebranded from University Compounding Pharmacy on July 1, 2024 |
Accreditation claims are the pharmacy's own; we could not check them against LegitScript's or ACHC's lookups, which were not publicly reachable. Every other row cites a source listed below.
What the public record shows
We found no FDA warning letters, Form 483s, recalls or state disciplinary actions for MediVera from 2023 through October 14, 2026. The only FDA record we found is a 2014 Form 483 response filed under its former name, University Compounding Pharmacy. Absence of a record is not a certification; check the Michigan license and any state where you live.
GLP-1 products
MediVera's weight-management page (dated August 10, 2026) lists compounded liraglutide injection (6 mg/mL) and sermorelin nasal spray. A 2024 post mentioned semaglutide. We did not find a current tirzepatide listing, so if a program says your tirzepatide comes from MediVera, confirm it on your vial label.
Why people search for MediVera and tirzepatide
Search Console shows readers looking for "medivera compounding pharmacy tirzepatide." We found no telehealth company that names MediVera as its tirzepatide pharmacy on its own site as of October 14, 2026.
How to verify this pharmacy yourself
Read the dispensing pharmacy's name on your vial label, then check its license with your state board of pharmacy, search the FDA outsourcing facility list if it claims 503B status, and scan the FDA's compounding inspections and actions page. Our 503A vs 503B guide explains the difference.
What MediVera told the FDA about tirzepatide in 2024
On December 12, 2024, a MediVera employee submitted a public comment to FDA docket FDA-2015-N-0030. The comment said the pharmacy prepares compounded tirzepatide and semaglutide in its sterile lab and that "We are PCAB accredited." It gave the address 6054 Livernois Rd.; the pharmacy's website now gives 5225 Crooks Rd, Troy.
One week later, on December 19, 2024, the FDA declared the tirzepatide shortage resolved. Enforcement discretion for 503A pharmacies ended after a federal court denied a preliminary injunction on March 5, 2025. Since then, a 503A pharmacy may not compound essentially-copy tirzepatide regularly or in inordinate amounts. The FDA says it will not act when a pharmacy fills four or fewer such prescriptions in a calendar month.
MediVera's weight-management page, dated August 10, 2026, lists compounded liraglutide and sermorelin and no tirzepatide. Its public pages do not say whether it still makes tirzepatide for individual prescriptions.
How does liraglutide differ from tirzepatide?
MediVera lists liraglutide at 6 mg/mL, the same concentration as the Saxenda and Victoza pens. Liraglutide and tirzepatide are different drugs with different dosing:
| Liraglutide (Saxenda for weight) | Tirzepatide (Zepbound for weight) | |
|---|---|---|
| How it works | GLP-1 receptor agonist | GIP and GLP-1 receptor agonist |
| How often | Once daily | Once weekly |
| Dose range | 0.6 mg rising weekly to 3.0 mg | 2.5 mg rising by 2.5 mg every 4 weeks or more, up to 15 mg |
| Key weight trial | SCALE (56 weeks): about 8.0% average loss vs 2.6% with placebo | SURMOUNT-1 (72 weeks): 15.0%, 19.5% and 20.9% at 5, 10 and 15 mg vs 3.1% with placebo |
Both trials enrolled adults with obesity, or overweight with a weight-related condition, who did not have type 2 diabetes. They tested FDA-approved products, not compounded versions. They were separate trials, so their results cannot be compared directly. Compounded liraglutide is not FDA-approved. The FDA's April 30, 2026 proposal to keep liraglutide, semaglutide and tirzepatide off the 503B bulks list had not been finalized as of November 4, 2026. That proposal affects outsourcing facilities, not 503A pharmacies like MediVera.
Records we checked for MediVera
| Check | Where | Result |
|---|---|---|
| 503B registration | FDA registered outsourcing facility list (updated October 29, 2026) | Not listed |
| Form 483s and other inspection records | FDA pharmacy inspection pages for 2023, 2024, 2025 and 2026 (2026 page current as of August 19, 2026) | No MediVera, Diversified Pharmacy or University Compounding entries |
| Warning letters, recalls | FDA warning-letter search and compounding actions page | None found for 2023–2026 |
| Provider identity | NPI Registry, record 1982712352 | Listed |
| State license | Michigan Department of Licensing and Regulatory Affairs (LARA) | Check yourself; also check your own state's board |
| Accreditation | ACHC (which runs PCAB) and LegitScript | Claimed by MediVera; not independently verified |
An empty record means we found nothing. It does not certify quality. Our 503A vs 503B guide explains what each license allows.
Questions to ask if a program says MediVera fills your GLP-1
- Which drug, at what concentration, will the label show: tirzepatide, semaglutide or liraglutide?
- Does the product contain any additive, and why?
- What is the prescriber's documented clinical reason for a compounded product instead of an approved one? The FDA's 2026 policy requires one for essentially-copy products made more than four times a month.
- Is MediVera licensed in your state? It says 49 states. Ask which state it does not ship to.
- Will the same pharmacy fill every refill?
As of October 14, 2026, we found no telehealth program that names MediVera on its own site, so a program's claim is worth checking against your first vial label.
More questions
Has MediVera ever compounded tirzepatide?
In a December 12, 2024 public comment to the FDA, a MediVera employee wrote that the pharmacy prepares compounded tirzepatide and semaglutide in its sterile lab. Its current weight-management page does not list tirzepatide.
Is MediVera on the FDA's 2026 pharmacy inspection records page?
No. None of the 25 entries on that page, current as of August 19, 2026, is MediVera or its former name.
What strength of liraglutide does MediVera list?
6 mg/mL, the same concentration as the FDA-approved Saxenda and Victoza pens. MediVera's version is compounded and is not FDA-approved.
Further sources
- FDA: Registered Outsourcing Facilities (list updated October 29, 2026)
- FDA: 2026 pharmacy inspections and related records (content current as of August 19, 2026)
- FDA: 2025 pharmacy inspections and related records
- FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (updated April 1, 2026)
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022
Frequently asked questions
Is MediVera a 503A or 503B pharmacy?
503A. MediVera says it "operates as a 503A compounding pharmacy," and it is not on the FDA's registered outsourcing facility list.
Does MediVera compound tirzepatide?
Its current weight-management page lists liraglutide, not tirzepatide (checked October 14, 2026).
Is MediVera the same as University Compounding Pharmacy?
Yes. University Compounding Pharmacy announced its rebrand to MediVera Compounding Pharmacy on July 1, 2024.
Sources
Other pharmacy profiles: Empower Pharmacy · Hallandale Pharmacy · Red Rock Pharmacy · Strive Pharmacy · Absolute Pharmacy · all pharmacies
Informational only. A pharmacy profile is not an endorsement. Compounded drugs are not FDA-approved.